Expression of calcitonin gene-related peptide, adrenomedullin, and receptor modifying proteins in human adipose tissue and alteration in their expression with menopause status

Menopause

Volumn 14, Issue 6, 2007, Pages 1031-1038

  Gupta, Pratima ^a,b   Harte, Alison L ^b   Da Silva, Nancy F ^b   Khan, Hassan ^b   Barnett, Anthony H ^c   Kumar, Sudhesh ^b   Sturdee, David W ^a   McTernan, Philip G ^b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY HOSPITALS COVENTRY AND WARWICKSHIRE NHS TRUST   (United Kingdom)

^c UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

Author keywords

Adipose tissue; Adrenomedullin; Calcitonin gene related peptide; Menopause; Receptor modifying proteins

Indexed keywords

ADRENOMEDULLIN; CALCITONIN GENE RELATED PEPTIDE; ESTRADIOL; FOLLITROPIN; RECEPTOR ACTIVITY MODIFYING PROTEIN;

ABDOMINAL FAT; ABDOMINAL SUBCUTANEOUS FAT; ADIPOCYTE; ADIPOSE TISSUE; ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MENOPAUSE; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; OMENTUM; POSTMENOPAUSE; PREMENOPAUSE; PROADIPOCYTE; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE;

ADIPOSE TISSUE; ADRENOMEDULLIN; ADULT; CALCITONIN GENE-RELATED PEPTIDE; CASE-CONTROL STUDIES; DNA PRIMERS; ESTROGEN RECEPTOR MODULATORS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MENOPAUSE; MIDDLE AGED; PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 36049046993     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/gme.0b013e31803c56b6     Document Type: Article

References (44)

1. Toth MJ, Tchernof A, Sires CK, Poehlman ET. Menopause-related changes in body fat distribution. Ann N Y Acad Sci 2000;904:502-506.
2. Gallicchio L, Visvanathan K, Miller SR, et al. Body mass, estrogen levels, and hot flashes in midlife women. Am J Obstet Gynecol 2005;193:1353-1360.
3. Whiteman MK, Staropoli CA, Benedict JC, Borgeest C, Flaws JA. Risk factors for hot flashes in midlife women. J Women Health (Larchmt) 2003;12:459-472.
4. Gold EB, Sternfed B, Kelsey JL, et al. Relation of demographic and lifestyle factors to symptoms in a multi-racial/ethnic population of women 40-55 years of age. Am J Epidemiol 2000;152:463-473.
5. Chiechi LM, Ferreri R, Granieri M, Bianco G, Berardesca C, Loizzi P. Climacteric syndrome and body-weight. Clin Exp Obstet Gynecol 1997;24:163-166.
6. Wilbur J, Miller AM, Montgomery A, Chandler P. Sociodemographic characteristics, biological factors, and symptom reporting in midlife women. Menopause 1998;5:43-51.
7. Freeman EW, Sammel MD, Grisso JA, Battisni M, Garcia-Espagna B, Hollander L. Hot flashes in the late reproductive years: risk factors for African American and Caucasian women. J Womens Health Gend Based Med 2001;10:67-76.
8. Chen JT, Hirai Y, Seimiya Y, Hasumi K, Shiraki M. Menopausal flushes and calcitonin-gene-related peptide. Lancet 1993;342:49.
9. Wyon Y, Spetz AE, Theodorsson GE, Hammar ML. Concentration of calcitonin gene-related peptide and neuropeptide Y in plasma increases during flushes in postmenopausal women. Menopause 2000;7:25-30.
10. Spetz AE, Pettersson B, Varenhorst E, Theodorsson E, Thorell LH, Hammar ML. Momentary increase in plasma calcitonin gene related peptide is involved in hot flashes in men treated with castration for carcinoma of the prostate. J Urol 2001;166:1720-1723.
11. Yallampalli C, Chauhan M, Thota CS, Kondapaka S, Wimalawansa SJ. Calcitonin gene-related peptide in pregnancy and its emerging receptor heterogeneity. Trends Endocrinol Metab 2002;13:263-269.
12. Gangula PR, Wimalawansa SJ, Yallampalli C. Pregnancy and sex steroid hormones enhance circulating calcitonin gene-related peptide concentrations in rats. Hum Reprod 2000;15:949-953.
13. Spinetti A, Margutti A, Bertolini S, et al. Hormonal replacement therapy affects calcitonin gene-related peptide and atrial natriuretic peptide secretion in postmenopausal women. Eur J Endocrinol 1997;137:664-669.
14. Di Iorio R, Marinoni E, Letizia C, Villaccio B, Alberini A, Cosmi EV. Adrenomedullin production is increased in normal human pregnancy. Eur J Endocrinol 1999;140:201-206.
15. Marinoni E, Di Iorio R, Letizia C, et al. Changes in plasma adrenomedullin levels during the menstrual cycle. Regul Pept 2000;87:15-18.
16. Amara SG, Arriza JL, Leff SE, Swanson LW, Evans RM, Rosenfeld MG. Expression in brain of a messenger RNA encoding a novel neuropeptide homologous to calcitonin gene related peptide. Science 1985;229:1094-1097.
17. Mulderry PK, Ghatei MA, Spokes RA, et al. Differential expression of α-CGRP and β-CGRP by primary sensory neurons and enteric autonomic neurons in the rat. Neuroscience 1988;25:195-205.
18. Hay DL, Howitt SG, Conner AC, Schindler M, Smith DM, Poyner DR. CL/RAMP2 and CL/RAMP3 produce pharmacologically distinct adrenomedullin receptors: a comparison of effects of adrenomedullin receptors: a comparison of effects of adrenomedullin 22-52, CGRP6-37 and BIBN4096BS. Br J Pharmacol 2003;140:477-486.
19. Wu D, Eberlein W, Rudolf K, Engel W, Hallermayer G, Doods H. Characterization of calcitonin gene-related peptide receptors in the rat atrium and vas deference: evidence for a [Cys(Et)(2,7)] hCGRP-preferring receptor. Eur J Pharmacol 2000;400:313-319.
20. Beltowski J, Jamroz A. Adrenomedullin - what do we know 10 years since discovery? Pol J Pharmacol 2004;56:5-27.
21. Kohno M, Hanehira T, Kano H, et al. Plasma adrenomedullin concentrations in essential hypertension. Hypertension 1996;27:102-107.
22. Takahashi K. Adrenomedullin from a pheochromocytoma to the eye: implications of the adrenomedullin research for endocrinology in the 21st century. Exp Med 2001;193:79-114.
23. Le Greves P, Nyberg F, Hokfelt T, Terenius L. Calcitonin gene-related peptide is metabolized by an endopeptidase hydrolyzing substance P. Regul Pept 1989;25:277-286.
24. Uddman R, Edvinsson L, Ekblad E, Hakanson R, Sundler F. Calcitonin gene related peptide (CGRP): perivascular distribution and vasodilatory effects. Regul Pept 1986;15:1-23.
25. Poyner DR, Sexton PM, Marshall I, et al. International union of pharmacology. XXXII. The mammalian calcitonin gene related peptides, adrenomedullin, amylin and calcitonin receptors. Pharmacol Rev 2002;54:233-246.
26. Rodbell M. Metabolism of isolated adipocytes. Effects of hormones on glucose metabolism and lipolysis. J Biol Chem 1964;239:375-380.
27. McTernan PG, McTernan CL, Chetty R, et al. Increased resistin gene and protein expression in human abdominal adipose tissue. J Clin Endocrinol Metab 2002;87:2407-2410.
28. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:807-811.
29. Linscheid P, Seboek D, Schaer DJ, Zulewski H, Keller U, Muller B. Expression and secretion of procalcitonin and calcitonin gene-related peptide by adherent monocytes and by macrophage-activated adipocytes. Crit Care Med 2004;32:1715-1721.
30. Linscheid P, Seboek D, Zulewski H, Keller U, Muller B. Autocrine/paracrine role of inflammation-mediated calcitonin gene-related peptide and adrenomedullin expression in human adipose tissue. Endocrinology 2005;146:2699-2708.
31. Hay DL, Howitt SG, Conner AC, Schindler M, Smith DM, Poyner DR. CL/RAMP2 and CL/RAMP3 produce pharmacologically distinct adrenomedullin receptors: a comparison of effects of adrenomedullin 22-52, CGRP8-37 and BIBN4096BS. Br J Pharmacol 2003;140:477-486.
32. Freedman RR. Hot flushes revisited. Menopause 2000;7:3-4.
33. Charkoudin N. Skin blood flow in adult human thermoregulation: how it works, when it does not, and why. Mayo Clin Proc 2003;78:603-612.
34. Bartness TJ, Kay Song C, Shi H, Bowers RR, Foster MT. Brain-adipose tissue talk. Proc Nutr Soc 2005;64:53-64.
35. Giordano A, Morroni M, Carle F, Gesuita R, Marchesi GF, Cinti S. Sensory nerves affect the recruitment and differentiation of rat periovarian brown adipocytes during cold acclimation. J Cell Sci 1998;111:2587-2594.
36. Kumazawa K, Sobue G, Mitsuma T, Ogawa T. Local effects of calcitonin gene-related peptide on human sweat gland function. Rinsho Shinkeigaku 1991;31:564-566.
37. Prineas RJ, Folsom AR, Kaye SA. Central adiposity and increased risk of coronary artery disease mortality in older women. Ann Epidemiol 1993;3:35-41.
38. Montague CT, O'Rahilly S. The perils of portliness: causes and consequences of visceral adiposity. Diabetes 2000;49:883-888.
39. Wimalawansa SJ. Age-related increase of calcitonin gene-related peptide in rat thyroid and circulation. Peptides 1991;12:1143-1147.
40. Schifter S. Circulatory concentrations of calcitonin gene-related peptide (CGRP) in normal men determined with a new, highly sensitive radioimmunoassay. Peptides 1991;12:365-369.
41. Zaidi M, Abeyasekera G, MacIntyre I. Calcitonin gene-related peptide: endocrine distribution and characterization of circulating forms. J Endocrinol Invest 1989;12:699-704.
42. Fukai N, Yoshimoto T, Sugiyama T, et al. Concomitant expression of adrenomedullin and its receptor components in rat adipose tissues. Am J Physiol Endocrinol Metab 2005;288:E56-E62.
43. Harmancey R, Senard JM, Pathak A, et al. The vasoactive peptide adrenomedullin is secreted by adipocytes and inhibits lipolysis through NO-mediated β-adrenergic agonist oxidation. FASEB J 2005;19:1045-1047.
44. Meeran K, O'Shea D, Upton PD, et al. Circulating adrenomedullin does not regulate systemic blood pressure but increases plasma prolactin after intravenous infusion in humans: a pharmacokinetic study. J Clin Endocrinol Metab 1997;82:95-100.